United States · FDA National Drug Code directory
Levocetirizine Dihydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-122_3b48813c-9d13-7de6-e063-6294a90ac278
- Product NDC
- 42571-122
- Form
- TABLET, FILM COATED
- Composition / generic term
- levocetirizine Dihydrochloride
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130930
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOCETIRIZINE DIHYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (42571-122-05) · 42571-122-05
- 30 TABLET, FILM COATED in 1 BOTTLE (42571-122-30) · 42571-122-30
- 10 BLISTER PACK in 1 CARTON (42571-122-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK (42571-122-11) · 42571-122-32
- 90 TABLET, FILM COATED in 1 BOTTLE (42571-122-90) · 42571-122-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →